Literature DB >> 31306323

National Partnership for Maternal Safety: Consensus Bundle on Obstetric Care for Women With Opioid Use Disorder.

Elizabeth E Krans1, Melinda Campopiano, Lisa M Cleveland, Daisy Goodman, Deborah Kilday, Susan Kendig, Lisa R Leffert, Elliott K Main, Kathleen T Mitchell, David T O'Gurek, Robyn D'Oria, Deidre McDaniel, Mishka Terplan.   

Abstract

The opioid epidemic is a public health crisis, and pregnancy-associated morbidity and mortality due to substance use highlights the need to prioritize substance use as a major patient safety issue. To assist health care providers with this process and mitigate the effect of substance use on maternal and fetal safety, the National Partnership for Maternal Safety within the Council on Patient Safety in Women's Health Care has created a patient safety bundle to reduce adverse maternal and neonatal health outcomes associated with substance use. The Consensus Bundle on Obstetric Care for Women with Opioid Use Disorder provides a series of evidence-based recommendations to standardize and improve the quality of health care services for pregnant and postpartum women with opioid use disorder, which should be implemented in every maternity care setting. A series of implementation resources have been created to help providers, hospitals, and health systems translate guidelines into clinical practice, and multiple state-level Perinatal Quality Collaboratives are developing quality improvement initiatives to facilitate the bundle-adoption process. Structure, process, and outcome metrics have also been developed to monitor the adoption of evidence-based practices and ensure consistency in clinical care.

Entities:  

Mesh:

Year:  2019        PMID: 31306323     DOI: 10.1097/AOG.0000000000003381

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Early lessons from maternal mortality review committees on drug-related deaths-time for obstetrical providers to take the lead in addressing addiction.

Authors:  Marcela C Smid; Charles W Schauberger; Mishka Terplan; Tricia E Wright
Journal:  Am J Obstet Gynecol MFM       Date:  2020-07-15

2.  Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy - 34 U.S. Jurisdictions, 2019.

Authors:  Jean Y Ko; Denise V D'Angelo; Sarah C Haight; Brian Morrow; Shanna Cox; Beatriz Salvesen von Essen; Andrea E Strahan; Leslie Harrison; Heather D Tevendale; Lee Warner; Charlan D Kroelinger; Wanda D Barfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-07-17       Impact factor: 17.586

3.  Non-pharmacological care for opioid withdrawal in newborns.

Authors:  Adrienne Pahl; Leslie Young; Madge E Buus-Frank; Lenora Marcellus; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2020-12-21

Review 4.  Pregnancy-Associated Deaths from Homicide, Suicide, and Drug Overdose: Review of Research and the Intersection with Intimate Partner Violence.

Authors:  Jacquelyn Campbell; Sabrina Matoff-Stepp; Martha L Velez; Helen Hunter Cox; Kathryn Laughon
Journal:  J Womens Health (Larchmt)       Date:  2020-12-08       Impact factor: 2.681

5.  Post-Cesarean Delivery Analgesic Outcomes in Patients Maintained on Methadone and Buprenorphine: A Retrospective Investigation.

Authors:  Joseph L Reno; Michael Kushelev; Julie H Coffman; Mona R Prasad; Avery M Meyer; Kristen M Carpenter; Marilly S Palettas; John C Coffman
Journal:  J Pain Res       Date:  2020-12-30       Impact factor: 3.133

6.  Implementation of a Prenatal Naloxone Distribution Program to Decrease Maternal Mortality from Opioid Overdose.

Authors:  M Duska; D Goodman
Journal:  Matern Child Health J       Date:  2022-01-14

7.  Postpartum and addiction recovery of women in opioid use disorder treatment: A qualitative study.

Authors:  Caitlin E Martin; Tawany Almeida; Bhushan Thakkar; Tiffany Kimbrough
Journal:  Subst Abus       Date:  2021-07-02       Impact factor: 3.716

8.  Polysubstance Use Among Pregnant Women With Opioid Use Disorder in the United States, 2007-2016.

Authors:  Marian P Jarlenski; Nicole C Paul; Elizabeth E Krans
Journal:  Obstet Gynecol       Date:  2020-09       Impact factor: 7.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.